Tech Company Financing Transactions
Cryosa Funding Round
On 9/27/2021, Cryosa received $21.5 million in Series B funding from Solas Bioventures, Hoya and Sante Ventures.
Transaction Overview
Company Name
Announced On
9/27/2021
Transaction Type
Venture Equity
Amount
$21,500,000
Round
Series B
Investors
Proceeds Purpose
The funding will be used to continue first-in-human clinical trials.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1265 Grey Fox Rd. 5
Arden Hills, MN 55112
USA
Arden Hills, MN 55112
USA
Phone
Undisclosed
Website
Email Address
Overview
Cryosa is a medical device company focused on developing breakthrough, minimally invasive and permanent therapies for obstructive sleep apnea (OSA). Driven by an experienced medical device team of successful startup entrepreneurs and large med-tech engineers, the company is based in Medical Alley, Minnesota.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Christopherson
Chief Medical Officer
Donald Gonzales
Vice President
Kris Selander
VP - R & D
Darrin Dickerson
Browse more venture capital transactions:
Prev: 9/27/2021: Emerge Freight venture capital transaction
Next: 9/27/2021: Spotnana Technology venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs